Insulet Brings in 2 Big Partnerships with CGM Powerhouses Abbott and DexCom
Insulet has snared two partnerships that will help it continue its strong momentum in the continuous glucose monitoring (CGM) market. The Billerica, MA-based company and one of the 25 most attractive medtech firms on the M&A radar, announced it had signed agreements with both Abbott Laboratories and DexCom. The agreements center around Insuletâs Omnipod Horizon Automated Insulin Delivery (AID) System, which is in pivotal trials in the U.S. The Omnipod Horizon System will be integrated with Abbottâs Freestyle Libre 2, which has approval in Europe. The Freestyle Libre 2 has not yet received a nod from FDA and is one of the most anticipated technologies to hit the U.S. market. The companies said this integrated system will be designed to always remain in automated insulin delivery mode and can be controlled through an app on a user's personal smartphone to manually take a dose of fast-acting insulin, or bolus, before meals for optimal performance. Additionally, the integrated platform is expected to be the first combined system with a fully disposable wearable sensor and pump. âAs diabetes care becomes more interoperable, we're developing more connected approaches to improve care,â Jared Watkin, senior vice president, Diabetes Care, Abbott, said in a release.âThrough this partnership, Abbott and Insulet will offer an integrated digital health platform that is simple and accurate and will pr...
Publication date: Available online 6 April 2020Source: Indian Heart JournalAuthor(s): Samit Ghosal, Binayak Sinha, Jignesh Ved, Mansij Biswas
Purpose of review Hyperlipidemia, hypertension, diabetes and related metabolic disorders increase the risk for cardiovascular disease (CVD). Despite significant progress in the identification of key mechanisms and genetic polymorphisms linked to various CVDs, the rates of CVDs continue to escalate, underscoring the need to evaluate additional mechanisms for more effective therapies. Environment and lifestyle changes can alter epigenetic mechanisms mediated by histone modifications and long noncoding RNAs (lncRNAs) which play important roles in gene regulation. The review summarizes recent findings on the role of epigenet...
After 12 weeks of mat Pilates, obese young women with high blood pressure lost body fat and had significantly improved blood pressure compared with those who didn't participate.Medscape Medical News
Condition: Diabetic Foot Ulcer Interventions: Device: PulseFlow DF boot; Device: Usual standard of care; Device: Sham Sponsors: University of Leeds; The Leeds Teaching Hospitals NHS Trust Completed
Condition: Type1diabetes Intervention: Behavioral: 4T Education and Care Sponsors: Stanford University; National Institutes of Health (NIH); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting
Conditions: Non-Alcoholic Fatty Liver Disease; Diabetes Mellitus, Type 2 Intervention: Device: LiverMultiscan Sponsor: Perspectum Diagnostics Ltd Not yet recruiting
Conclusions The results of this study highlight the key role that expert nurses play in the care of patients with DFS. Expert nurses considered that amputation leaves the individual physically and psychologically vulnerable, especially upon discharge from hospital. It is therefore essential to provide these patients with comprehensive and multidisciplinary care that includes emotional support.
Is this primary aldosteronism subtype associated with an increased risk for vertebral fracture?Clinical Endocrinology
DiabetesMine explains how stress makes your blood sugar rise, and what you can do about it.
DiabetesMine reports on new national telehealth rules and changes to medication refills critical for diabetes care.